BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2427603)

  • 1. Ontogeny of Langerhans cells in human embryonic and fetal skin: expression of HLA-DR and OKT-6 determinants.
    Foster CA; Holbrook KA; Farr AG
    J Invest Dermatol; 1986 Mar; 86(3):240-3. PubMed ID: 2427603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ontogeny of Langerhans cells in human embryonic and fetal skin: cell densities and phenotypic expression relative to epidermal growth.
    Foster CA; Holbrook KA
    Am J Anat; 1989 Feb; 184(2):157-64. PubMed ID: 2712007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional development of Langerhans cells and formation of Birbeck granules in human embryonic and fetal skin.
    Fujita M; Furukawa F; Horiguchi Y; Ueda M; Kashihara-Sawami M; Imamura S
    J Invest Dermatol; 1991 Jul; 97(1):65-72. PubMed ID: 1711549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermal Langerhans cell involvement in cutaneous lupus erythematosus.
    Sontheimer RD; Bergstresser PR
    J Invest Dermatol; 1982 Oct; 79(4):237-43. PubMed ID: 6215451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential distribution of Langerhans cells in organ culture of human skin.
    Elmets CA; Bergstresser PR; Streilein JW
    J Invest Dermatol; 1982 Nov; 79(5):340-5. PubMed ID: 6215452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ontogeny of Ia-positive and Thy-1-positive leukocytes of murine epidermis.
    Romani N; Schuler G; Fritsch P
    J Invest Dermatol; 1986 Feb; 86(2):129-33. PubMed ID: 2875114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Langerhans cells: methods of identification].
    Nicolas C; Schmitt D
    Pathol Biol (Paris); 1984 Mar; 32(3):199-208. PubMed ID: 6232489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of UVA and UVB irradiation on human epidermal Langerhans cell membrane markers defined by ATPase activity and monoclonal antibodies (OKT 6 and anti-Ia).
    Koulu L; Jansén CT; Viander M
    Photodermatol; 1985 Dec; 2(6):339-46. PubMed ID: 2937025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
    Czernielewski JM; Schmitt D; Faure MR; Thivolet J
    Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative and three-dimensional analysis of human Langerhans cells in epidermal sheets and vertical skin sections.
    Emilson A; Scheynius A
    J Histochem Cytochem; 1995 Oct; 43(10):993-8. PubMed ID: 7560889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Langerhans cells in epidermal cell culture, in vitro skin explants and skin grafts onto "nude" mice.
    Czernielewski J; Demarchez M; Prunieras M
    Arch Dermatol Res; 1984; 276(5):288-92. PubMed ID: 6593008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon enhancement of HLA-DR antigen expression on epidermal Langerhans cells.
    Berman B; Duncan MR; Smith B; Ziboh VA; Palladino M
    J Invest Dermatol; 1985 Jan; 84(1):54-8. PubMed ID: 2578172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting.
    Vaigot P; Czernielewski J; Prunieras M
    Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ontogeny and characterization of factor XIIIa+ cells in developing human skin.
    Gibran NS; Nickoloff BJ; Holbrook KA
    Anat Embryol (Berl); 1996 Jan; 193(1):35-41. PubMed ID: 8838494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Langerhans cells, immunomodulation and skin lesions. A quantitative, morphological and clinical study.
    Bergfelt L
    Acta Derm Venereol Suppl (Stockh); 1993; 180():1-37. PubMed ID: 7901956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The appearance, density and distribution of melanocytes in human embryonic and fetal skin revealed by the anti-melanoma monoclonal antibody, HMB-45.
    Holbrook KA; Underwood RA; Vogel AM; Gown AM; Kimball H
    Anat Embryol (Berl); 1989; 180(5):443-55. PubMed ID: 2619087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PUVA therapy decreases HLA-DR+ CDIa+ Langerhans cells and epidermal cell antigen-presenting capacity in human skin, but flow cytometrically-sorted residual HLA-DR+ CDIa+ Langerhans cells exhibit normal alloantigen-presenting function.
    Ashworth J; Kahan MC; Breathnach SM
    Br J Dermatol; 1989 Mar; 120(3):329-39. PubMed ID: 2469456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.